Maternal Risk Factors for Autism Spectrum Disorders: A Case-Control Approach
1 other identifier
observational
239
1 country
1
Brief Summary
New research suggests that about 1 in 8 children may be diagnosed with an autism spectrum disorder (ASD) in the United States. This could be due to several reasons which remain unknown. This study invites mothers who have given birth to children in the United States to share their experiences with diet and supplementation during pregnancy. The purpose of this study is to understand the role of a mother's diet, social standing, and supplementation with folate or folic acid may have on her child's future development of autism. Comparisons will be made between mothers of children who have a child with an official ASD diagnosis from a clinician to mothers of children without an ASD diagnosis. Findings from this study can be used to help identify risk factors for ASD risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 16, 2022
CompletedFirst Submitted
Initial submission to the registry
July 6, 2022
CompletedFirst Posted
Study publicly available on registry
July 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2023
CompletedMarch 20, 2023
March 1, 2023
7 months
July 6, 2022
March 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association between maternal folate intake during pregnancy and the occurrence of ASD in the offspring via questionnaire.
Number of participants with a child diagnosed with ASD who used multivitamins or folate/folic acid supplements during pregnancy as assessed by the questionnaire.
42 weeks gestation
Secondary Outcomes (1)
Association between mother's co-morbidities and the occurrence of ASD in offspring via questionnaire.
42 weeks gestation
Study Arms (2)
Autism Risk
Survey for mothers 18 years or older with a child aged 3-12 years who has an official ASD diagnosis from a clinician.
Controls
Survey for mothers 18 years or older of children aged 3-12 years who do not have an ASD diagnosis so comparisons can be made between groups.
Interventions
Eligibility Criteria
This survey asks mothers to provide information about their experiences with diet and supplementation during pregnancy.
You may qualify if:
- Mothers 18 years or older with a child aged 3-12 years who have an official ASD diagnosis from a clinician
- Mothers 18 years or older of children aged 3-12 years who do not have an ASD diagnosis so comparisons can be made between groups
You may not qualify if:
- Mothers outside of the United States
- Mothers less than 18 years of age
- Mothers who have not given birth to their child or who used a surrogate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Walden University
Minneapolis, Minnesota, 55401, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael M Haniff
Student
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 6, 2022
First Posted
July 12, 2022
Study Start
June 16, 2022
Primary Completion
January 22, 2023
Study Completion
January 22, 2023
Last Updated
March 20, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share